UTHR - United Therapeutics - Stock Price & Dividends

United Therapeutics Corporation is a biotechnology company that focuses on developing and commercializing innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases. The company's mission is to improve the lives of patients worldwide, and it achieves this by creating novel treatments that cater to specific medical conditions.

The company's product portfolio includes Tyvaso DPI, an inhaled dry powder medication delivered through pre-filled and single-use cartridges, and Tyvaso, an inhaled solution administered via an ultrasonic nebulizer. Both products are designed to treat patients with pulmonary arterial hypertension (PAH), a condition that affects the blood vessels in the lungs. Additionally, United Therapeutics offers Remodulin, an injection that helps alleviate symptoms associated with exercise in PAH patients, and Orenitram, a tablet form of treprostinil that delays disease progression and improves exercise capacity in PAH patients.

United Therapeutics also markets and sells Unituxin, a monoclonal antibody used to treat high-risk neuroblastoma, a type of cancer that affects children. Furthermore, the company offers the Remunity Pump, a device that contains a pump and separate controller for Remodulin administration. The company's product pipeline is robust, with several promising candidates in development, including RemoPro and Ralinepag for the treatment of PAH, Aurora-GT, a gene therapy product aimed at rebuilding blood vessels in the lungs, and Nebulized Tyvaso, a treatment for idiopathic pulmonary fibrosis.

The company has established strategic partnerships with other industry players, such as DEKA Research & Development Corp., MannKind Corporation, and Arena Pharmaceuticals, Inc. These collaborations enable United Therapeutics to leverage the expertise and resources of its partners to accelerate the development and commercialization of its products. Founded in 1996, United Therapeutics is headquartered in Silver Spring, Maryland, and is committed to improving the lives of patients worldwide through its innovative products and therapies.